Found: 14
Select item for more details and to access through your institution.
Biomarkers and their impact on precision medicine.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 211, doi. 10.1177/1535370217733426
- By:
- Publication type:
- Article
Biomarker definitions and their applications.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 213, doi. 10.1177/1535370217750088
- By:
- Publication type:
- Article
Preclinical biomarker qualification.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 222, doi. 10.1177/1535370217743949
- By:
- Publication type:
- Article
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 228, doi. 10.1177/1535370217739859
- By:
- Publication type:
- Article
Mouse population-based evaluation of urinary protein and miRNA biomarker performance associated with cisplatin renal injury.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 237, doi. 10.1177/1535370217740854
- By:
- Publication type:
- Article
Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 248, doi. 10.1177/1535370217746383
- By:
- Publication type:
- Article
Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 256, doi. 10.1177/1535370217739629
- By:
- Publication type:
- Article
Liquid biopsy and its role in an advanced clinical trial for lung cancer.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 262, doi. 10.1177/1535370217750087
- By:
- Publication type:
- Article
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 272, doi. 10.1177/1535370217745302
- By:
- Publication type:
- Article
MicroRNAs as biomarkers for clinical studies.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 283, doi. 10.1177/1535370217731291
- By:
- Publication type:
- Article
Biomarkers of adverse drug reactions.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 291, doi. 10.1177/1535370217733425
- By:
- Publication type:
- Article
In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 300, doi. 10.1177/1535370217740853
- By:
- Publication type:
- Article
The FDA Oncology Center of Excellence and precision medicine.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 308, doi. 10.1177/1535370217740861
- By:
- Publication type:
- Article
Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 3, p. 313, doi. 10.1177/1535370217744775
- By:
- Publication type:
- Article